Allo - Cancer - Thrombosis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Enrollment
- 100
- Primary Endpoint
- Percentage of patients with appropriate care of venous thromboembolism
- Last Updated
- 7 years ago
Overview
Brief Summary
Management of venous thromboembolism (VTE) in patients with cancer is complex and require the intervention of many specialized health professionals, in hospital but also at home and during follow-up.
The AlloTC project aims to integrate the management of VTE within the multidisciplinary care pathway of the patient with cancer, in order to improve the management of VTE in patients with cancer: optimize treatments and follow-up with appropriate anticoagulants, monitor the implementation of good clinical practice, promote patient involvement and adherence.
The objective of this monocentric study is to evaluate the efficiency of the integration of the therapeutic management of VTE into a specific management of patient with cancer and to set up a specialized "AlloTC" team that coordinates this course of care.
For that purpose, the management of VTE and outcome of patients with cancer and VTE will be compared between two periods : traditional management and management with the "AlloTC" team.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of cancer or haematological malignancies
- •Venous thromboembolism diagnosis (symptomatic or not)
Exclusion Criteria
- •Life expectancy ≤ 3 months
- •Inability to understand or sign consent
- •Inability to read or understand the French language
Outcomes
Primary Outcomes
Percentage of patients with appropriate care of venous thromboembolism
Time Frame: at 6 months
Percentage of patients who received appropriate care of venous thromboembolism according to the latest International Good Clinical Practice (GCP) guidelines
Secondary Outcomes
- Number of patients under care for venous thromboembolism integrated into a personalized care plan as defined in the '' 2009-2013 Cancer Plan ''(at 6 months)
- Percentage of patients who had at least 1 session of specialized therapeutic education(at 6 months)
- Number of complications(at 6 months)
- Number of calls from health professionals to the AlloTC team(at 6 months)
- Number of patients referred to the coordinating nurse in Oncology service(at 6 months)
- Caregiver satisfaction survey concerning on the AlloTC team and care path(at 6 months)
- Hospitalization duration in the AlloTC cohort(at 6 months)
- Number of patients lost to follow-up(at 6 months)
- Assessment of the quality of life of the patient(at 6 months)
- Percentage of patients with appropriate care of venous thromboembolism(at 3 months)
- Number of patients evaluated at multidisciplinary meeting(at 6 months)
- Patient satisfaction survey concerning the AlloTC team and care path(at 6 months)
- Number of patients accessing the venous thromboembolism information documents.(at 6 months)
- Number of hospitalizations in the AlloTC cohort(at 6 months)